These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10852834)

  • 21. [Early detection and therapeutic rearing for children with mental retardation: II. Assessment of gene analyses for the diagnosis of developmental disorders in Japan].
    Horiguchi T; Kaga M; Inagaki M
    No To Hattatsu; 2002 Jul; 34(4):313-7. PubMed ID: 12134682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical profile of young children with mental retardation and developmental delay in Hong Kong.
    Tang KM; Chen TY; Lau VW; Wu MM
    Hong Kong Med J; 2008 Apr; 14(2):97-102. PubMed ID: 18382015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Environmental factors associated with a spectrum of neurodevelopmental deficits.
    Mendola P; Selevan SG; Gutter S; Rice D
    Ment Retard Dev Disabil Res Rev; 2002; 8(3):188-97. PubMed ID: 12216063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The assessment of neurobehavioral toxicity: SGOMSEC joint report.
    Fiedler N; Feldman RG; Jacobson J; Rahill A; Wetherell A
    Environ Health Perspect; 1996 Apr; 104 Suppl 2(Suppl 2):179-91. PubMed ID: 8860321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does methylmercury have a role in causing developmental disabilities in children?
    Myers GJ; Davidson PW
    Environ Health Perspect; 2000 Jun; 108 Suppl 3(Suppl 3):413-20. PubMed ID: 10852838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoamine oxidase a promoter gene associated with problem behavior in adults with intellectual/developmental disabilities.
    May ME; Srour A; Hedges LK; Lightfoot DA; Phillips JA; Blakely RD; Kennedy CH
    Am J Intellect Dev Disabil; 2009 Jul; 114(4):269-73. PubMed ID: 19642709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of array-based comparative genome hybridization in children with developmental delay or mental retardation.
    Liang JS; Shimojima K; Yamamoto T
    Pediatr Neonatol; 2008 Dec; 49(6):213-7. PubMed ID: 19166117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The developmental neurotoxicity of arsenic: cognitive and behavioral consequences of early life exposure.
    Tolins M; Ruchirawat M; Landrigan P
    Ann Glob Health; 2014; 80(4):303-14. PubMed ID: 25459332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environmental neurotoxicity of chemicals and radiation.
    Verity MA
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):437-42. PubMed ID: 8507914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic analysis of a patient featuring developmental delay and mental retardation].
    Bai N; Liu Y; Mei S; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Apr; 33(2):208-11. PubMed ID: 27060317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intellectual disability - a frequent reason for referral to medical genetics].
    Otte C; Rauch A
    Praxis (Bern 1994); 2013 Nov; 102(24):1467-73. PubMed ID: 24280603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 20.5-Mb germline deletion of 13q13.1-->q14.3 and somatic mutations of the RB1 gene in an 8-year-old girl with unilateral retinoblastoma, developmental delay and mental retardation.
    Chen CP; Kao LY; Su YN; Chen M; Chang SD; Wang W
    Genet Couns; 2011; 22(4):431-4. PubMed ID: 22303805
    [No Abstract]   [Full Text] [Related]  

  • 33. Neurobehavioral assessment of children and adolescents attending a developmental disabilities clinic.
    Brasić JR; Barnett JY; Kowalik S; Tsaltas MO; Ahmad R
    Psychol Rep; 2004 Dec; 95(3 Pt 2):1079-86. PubMed ID: 15762388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurodevelopmental toxicology.
    Schmid C; Rotenberg JS
    Neurol Clin; 2005 May; 23(2):321-36. PubMed ID: 15757787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
    Aman MG; Gharabawi GM;
    J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health care use and health and functional impact of developmental disabilities among US children, 1997-2005.
    Boulet SL; Boyle CA; Schieve LA
    Arch Pediatr Adolesc Med; 2009 Jan; 163(1):19-26. PubMed ID: 19124699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Environmental health and developmental disabilities: a life span approach.
    Tyler CV; White-Scott S; Ekvall SM; Abulafia L
    Fam Community Health; 2008; 31(4):287-304. PubMed ID: 18794636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The developing brain and the environment: an introduction.
    Weiss B; Landrigan PJ
    Environ Health Perspect; 2000 Jun; 108 Suppl 3(Suppl 3):373-4. PubMed ID: 10852830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Behavioral disorders and substance abuse in adolescents with mental retardation].
    Papachristou E; Anagnostopoulos D
    Psychiatriki; 2014; 25(2):139-50. PubMed ID: 25035183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral toxicology, risk assessment, and chlorinated hydrocarbons.
    Evangelista de Duffard AM; Duffard R
    Environ Health Perspect; 1996 Apr; 104 Suppl 2(Suppl 2):353-60. PubMed ID: 9182042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.